WallStreetZenWallStreetZen

NASDAQ: EWTX
Edgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Edgewise Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter A. ThompsonDirector2025-04-03372,578$20.13
$7.50MBuy
Orbimed Advisors LLCDirector2025-04-03124,193$20.13
$2.50MBuy
Orbimed Advisors LLCDirector2025-04-03372,578$20.13
$7.50MBuy
Peter A. ThompsonDirector2025-04-03124,193$20.13
$2.50MBuy
Alan J. RussellChief Scientific Officer2025-03-07200$30.02
$6.00kSell
Kevin KochPresident and CEO2025-03-07100$30.00
$3.00kSell
Kevin KochPresident and CEO2025-03-07100$0.18
$18.00Buy
Alan J. RussellChief Scientific Officer2025-03-07200$0.18
$36.00Buy
Kevin KochPresident and CEO2025-02-06900$13.11
$11.80kBuy
Alan J. RussellChief Scientific Officer2025-02-061,200$30.13
$36.15kSell

1 of 5

EWTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EWTX insiders and whales buy or sell their stock.

EWTX Shareholders

What type of owners hold Edgewise Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC15.78%15,021,721$235.54MInstitution
Ra Capital Management LP9.36%8,909,091$139.69MInstitution
Blackrock Inc6.81%6,479,015$101.59MInstitution
Baker Bros Advisors LP6.47%6,155,940$96.53MInstitution
Holdings A. Novo6.38%6,071,703$95.20MInsider
Novo Holdings A5.25%5,000,000$78.40MInstitution
Janus Henderson Group PLC5.23%4,983,940$78.15MInstitution
Paradigm Biocapital Advisors LP4.72%4,493,929$70.46MInstitution
Vanguard Group Inc4.69%4,466,849$70.04MInstitution
James E. Flynn4.13%3,933,137$61.67MInsider

1 of 3

EWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EWTX86.39%13.61%Net BuyingNet Buying
GPCR35.24%12.56%Net Buying
MNKD34.91%65.09%Net SellingNet Selling
IMCR91.87%4.35%Net BuyingNet Buying
VERA66.31%33.69%Net SellingNet Selling
View Top Biotech Stocks

Edgewise Therapeutics Stock Ownership FAQ

Who owns Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ: EWTX) is owned by 103.96% institutional shareholders, 16.37% Edgewise Therapeutics insiders, and 0.00% retail investors. Holdings A. Novo is the largest individual Edgewise Therapeutics shareholder, owning 6.07M shares representing 6.38% of the company. Holdings A. Novo's Edgewise Therapeutics shares are currently valued at $93.87M.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.